Home LiteratureArticle Details
PMID: 201566 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Alteration of host defense mechanisms by murine cytomegalovirus infection.

Infection and immunity ·Vol. 18 ·No. 3 ·1977-12-00 ·Pages 754-60

Kelsey DK, Olsen GA, Overall JC, Glasgow LA

Abstract

An animal model of a sublethal infection, utilizing murine cytomegalovirus (MCMV), was developed to determine whether immunological factors could contribute to the establishment of a persistent viral infection. Adult female C3H mice inoculated intraperitoneally with 10(5) plaque-forming units of MCMV developed splenomegaly 5 to 12 days after infection. Virus replicated to peak titers (10(3) to 10(6) plaque-forming units per g of tissue) in liver, spleen, lung, kidney, and salivary gland tissue during the acute phase of the infection (3 to 12 days); it then decreased to undetectable levels in all tissues except salivary gland. Serum interferon was detected as early as 12 h after infection, peaked at 36 h (1,093 U/ml), and was undetectable by 4 days after infection. MCMV-infected animals were hyporeactive to interferon induction with New castle disease virus on days 5 to 9 of the infection. Splenic lymphocyte reactivity to phytohemagglutinin and lipopolysaccharide was normal early during the course of the infection, was suppressed during the acute phase of the infection, and had returned to normal by day 18. These data indicate that several parameters of host defense are transiently suppressed during the course of a MCMV infection. The capacity of cytomegaloviruses to alter host resistance may be one factor that contributes to the establishment of a persistent infection.

MeSH Terms
Animals Cytomegalovirus/growth & development Cytomegalovirus Infections/immunology,microbiology Female Interferons/biosynthesis Kidney/microbiology Lectins Lipopolysaccharides Liver/microbiology Lung/microbiology Lymphocyte Activation Mice Mice, Inbred C3H Newcastle disease virus Spleen/microbiology Splenomegaly
Chemicals
Lectins Lipopolysaccharides Interferons
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kelsey D K
Olsen G A
Overall J C
Glasgow L A
References (25)
25 references, click to expand
  1. Lactic dehydrogenase activity in blood.
    Proc Soc Exp Biol Med. 1955 Oct;90(1):210-3 PMID: 13273400
  2. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.
    J Exp Med. 1976 Nov 2;144(5):1316-23 PMID: 186555
  3. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    J Infect Dis. 1977 Apr;135(4):540-51 PMID: 192804
  4. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.
    J Exp Med. 1976 Nov 2;144(5):1305-15 PMID: 186554
  5. Hyporeactivity due to infection: recognition of a transferable hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Infect Immun. 1974 Dec;10(6):1337-42 PMID: 4373396
  6. Tilorone hydrochloride: an oral interferon-inducing agent.
    Antimicrob Agents Chemother. 1972 Aug;2(2):73-8 PMID: 4670490
  7. Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity.
    Clin Exp Immunol. 1974 Sep;18(1):119-26 PMID: 4377713
  8. Mouse cytomegalovirus: isolation from spleen and lymph nodes of chronically infected mice.
    Proc Soc Exp Biol Med. 1972 Jul;140(3):802-6 PMID: 4339063
  9. Maternal cytomegalovirus excretion and perinatal infection.
    N Engl J Med. 1973 Jul 5;289(1):1-5 PMID: 4350775
  10. Latent cytomegalovirus infection in blood donors.
    Br Med J. 1969 Dec 13;4(5684):660-2 PMID: 4311727
  11. Prevalence and duration of postnatally acquired human cytomegalovirus infection.
    J Chronic Dis. 1970 Feb;22(8):603-7 PMID: 4314404
  12. Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations.
    Am J Pathol. 1966 Nov;49(5):871-88 PMID: 4288830
  13. Immunosuppression during acute murine cytomegalovirus infection.
    J Immunol. 1968 Apr;100(4):835-44 PMID: 4296301
  14. Plaque assay of cytomegalovirus strains of human origin.
    Proc Soc Exp Biol Med. 1970 Nov;135(2):253-8 PMID: 4320336
  15. Studies of relationship between mouse cytomegalovirus and interferon.
    Proc Soc Exp Biol Med. 1966 Mar;121(3):819-24 PMID: 4286949
  16. Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors.
    Cell Immunol. 1974 Jul;13(1):32-40 PMID: 4615809
  17. Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn mice.
    Antimicrob Agents Chemother. 1976 Mar;9(3):458-64 PMID: 176935
  18. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.
    J Immunol. 1976 May;116(5):1459-65 PMID: 178797
  19. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.
    J Exp Med. 1975 Mar 1;141(3):561-72 PMID: 163887
  20. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    N Engl J Med. 1975 Dec 4;293(23):1159-63 PMID: 171568
  21. The transplanted kidney as a source of cytomegalovirus infection.
    N Engl J Med. 1975 Nov 27;293(22):1109-12 PMID: 171567
  22. Stimulation of B-lymphocytes by endotoxin. Reactions of thymus-deprived mice and karyotypic analysis of dividing cells in mice bearing T 6 T 6 thymus grafts.
    J Immunol. 1972 Apr;108(4):1088-91 PMID: 5023169
  23. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.
    Clin Exp Immunol. 1971 Oct;9(4):483-98 PMID: 4941661
  24. Cellular immunity in host resistance to viral infections.
    Arch Intern Med. 1970 Jul;126(1):125-34 PMID: 5425510
  25. An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.
    Transplantation. 1968 Sep;6(6):761-4 PMID: 5706694
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1977-12-00
Pages
754-60
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC421299
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]